KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Staar Surgical (STAA) Cost of Revenue (2016 - 2026)

Staar Surgical (STAA) has disclosed Cost of Revenue for 17 consecutive years, with -$19.7 million as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Cost of Revenue fell 169.15% year-over-year to -$19.7 million, compared with a TTM value of $57.0 million through Jan 2026, down 51.25%, and an annual FY2026 reading of $57.0 million, down 51.25% over the prior year.
  • Cost of Revenue was -$19.7 million for Q1 2026 at Staar Surgical, down from $23.5 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $41.2 million in Q3 2024 and bottomed at -$19.7 million in Q1 2026.
  • Average Cost of Revenue over 5 years is $17.1 million, with a median of $16.9 million recorded in 2022.
  • The sharpest move saw Cost of Revenue plummeted 208.52% in 2023, then soared 283.81% in 2024.
  • Year by year, Cost of Revenue stood at $14.3 million in 2022, then tumbled by 208.52% to -$15.5 million in 2023, then skyrocketed by 283.81% to $28.4 million in 2024, then dropped by 17.52% to $23.5 million in 2025, then crashed by 183.83% to -$19.7 million in 2026.
  • Business Quant data shows Cost of Revenue for STAA at -$19.7 million in Q1 2026, $23.5 million in Q3 2025, and $38.6 million in Q2 2025.